Prism Medico & Pharmacy Limited has submitted a regulatory filing to stock exchanges confirming that it has not issued any non-convertible securities during the fourth quarter of fiscal year 2026. The intimation, dated 06/04/2026, was filed under Regulation 57(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Compliance Filing

The company addressed its communication to both BSE Limited and Metropolitan Stock Exchange of India Limited (MSEI), where its shares are listed. The filing serves as a mandatory disclosure requirement under SEBI LODR regulations for companies regarding their non-convertible securities status.

Company Information and Authorization

Prism Medico and Pharmacy Limited, incorporated under CIN L24100HP2002PLC009299, has its registered office located at Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030. The regulatory filing was authorized and signed by Davender Singh, Director of the company, holding DIN 09447213.

No Payment Obligations During Q4FY26

Since the company has not issued any non-convertible securities, it confirms that there were no interest, dividend, or principal payment obligations due during the quarter from 01st January, 2026 to 31st March, 2026. This confirmation is part of the company's ongoing compliance with regulatory disclosure requirements.

The filing represents routine regulatory compliance by the company to keep stock exchanges and investors informed about its securities status and related payment obligations.

Prism Medico & Pharmacy Limited has submitted another regulatory compliance intimation with stock exchanges regarding its non-convertible securities position. The company has confirmed that no non-convertible securities were issued during the latest reporting period.

Latest Regulatory Filing

The company filed its most recent intimation on April 6, 2026, addressing both BSE Limited and Metropolitan Stock Exchange of India Limited (MSEI). This filing was made pursuant to Regulation 57(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Non-Convertible Securities Confirmation

Prism Medico and Pharmacy Limited has declared that it has not issued any non-convertible securities during the quarter beginning January 1, 2026 and ending March 31, 2026. Consequently, there were no interest, dividend, or principal obligations due for payment during this period. This represents a continuation of the company's position on non-convertible securities.

Previous Compliance Record

The company had previously filed a similar intimation on March 30, 2026, under Regulation 57(4) for the quarter period April 1, 2026 to June 30, 2026, also confirming no non-convertible securities with payable obligations.

Company Information

The latest filing was signed by Davender Singh, Director of the company, bearing DIN: 09447213. The company operates under CIN: L24100HP2002PLC009299 with its registered office at Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030.